Entire Transcript in Adobe Acrobat Format - National Reference ...

220
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
is it going to do it? I mean, basically what you have
described is informed consent. I do not see how it is
anything different than informed consent. An advance
directive --
MS. BACKLAR: I tell you what is advance about
it.
DR. CHILDRESS: It may be an improvement --
MS. BACKLAR: The advance part of it is in a
sense the person is preparing in case they lose capacity
and at a time that they lose -- they should lose capacity
for decision making if they are in the research protocol,
which might involve coming off medications or various
things, that for sure they have with them a surrogate and
an outside provider. So in a sense that is the advance
part of it.
While they have capacity to make decisions for
themselves they will.
DR. CHILDRESS: But we could simply require
those mechanisms without connecting it with the notion of
an advance directive.
DR. EMANUEL: I also might mention that does
not apply well to the dementia category, which at least
from a numerical standpoint --
MS. BACKLAR: I understand that.